Evidence map›Paper›PMID 37176556›Full record

ArticleJournal of clinical medicine2023

The Risk of Malignant Degeneration of Müllerian Derivatives in PMDS: A Review of the Literature.

Federica Gagliardi, Augusto Lauro, Livia De Anna, Domenico Tripodi, Anna Esposito, Flavio Forte, Daniele Pironi, Eleonora Lori, Patrizia Alba Gentile, Ignazio R Marino and 2 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Federica GagliardiDepartment of Surgery, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0002-8860-8090
Augusto LauroDepartment of Surgery, Sapienza University of Rome, 00161 Rome, Italy.
Livia De AnnaDepartment of Surgery, Sapienza University of Rome, 00161 Rome, Italy.
Domenico TripodiDepartment of Surgery, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0002-4190-8168
Anna EspositoDepartment of Surgery, Sapienza University of Rome, 00161 Rome, Italy.
Flavio ForteUrology Department, M.G. Vannini Hospital, 00177 Rome, Italy.
Daniele PironiDepartment of Surgery, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0003-1545-0779
Eleonora LoriDepartment of Surgery, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0003-1943-4952
Patrizia Alba GentileDepartment of Surgery, Sapienza University of Rome, 00161 Rome, Italy.
Ignazio R MarinoSidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.ORCID 0000-0002-1519-8385
Ernesto T FigueroaDivision of Pediatric Urology, Nemours/Alfred I. DuPont Hospital for Children, Wilmington, DE 19803, USA.
Vito D'AndreaDepartment of Surgery, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0001-5709-2530
Sapienza University of Rome · ITDuPont (United States) · USThomas Jefferson University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Persistent Müllerian Duct Syndrome (PMDS) is a rare autosomal recessive disorder of sex development characterized by the presence of fallopian tubes, uterus and upper one-third of the vagina in individuals with XY genotype and normal male phenotype. The main complications of PMDS are infertility and the rare risk of malignant degeneration of both testicular and Müllerian derivatives. We report the case of a 49-year-old man who, during repair of an incisional hernia, was incidentally found to have a uterine-like structure posterior to the bladder. In the past at the age of 18 months, he had undergone bilateral orchidopexies for bilateral cryptorchidism. The intraoperative decision was to preserve the uterine-like structure and make a more accurate diagnosis postoperatively. Evaluation revealed an XY chromosome and imaging consistent with PMDS. The patient was informed about the risk of neoplastic transformation of the residual Müller ducts and was offered surgical treatment, which he declined. Subsequent follow-up imaging studies, including testicular and pelvic ultrasound, were negative for findings suggestive of malignant testicular and Mullerian derivative degeneration. A review of the international literature showed that, when a decision is taken to remove the Mullerian derivatives, laparoscopy and especially robotic surgery allow for the successful removal of Müllerian derivatives. Whenever the removal of these structures is not possible or the patient refuses to undergo surgery, it is necessary to inform the patient of the need for adequate follow-up. Patients should undergo regular pelvic imaging examination and MRI might be a better method for that purpose.

Indexed as

anti-Müllerian hormone (AMH)cryptorchidismmalignant degenerationorchipexypersistent Müllerian duct syndrome (PMDS)

Identifiers

PMID37176556
PMCPMC10179332
OpenAlexW4366991354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.